FINANCIALS

SUPN Supernus Pharmaceuticals Inc 1356576

Income Statement
Revenue	supn-20240930	175,689,000
Net Income	supn-20240930	38,497,000
Profit Margin		21.91%

Balance Sheet
Current Assets	640,003,000
Assets	1,342,701,000
Current Liabilities	291,508,000
Liabilities	335,551,000
Equity	1,007,150,000
Shares Out	55,105,000

Cash Flow Statement
Operating Cash Flow	127,545,000
Investing Cash Flow	-177,229,000

Market Analysis
Market Cap	1,746,841,222
Price	37.74
BVPS	18.28
PB	2.06
EPS	0.09
PE	359.05
PS	2.49
FCF	-49,684,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view SUPN documents filed with the SEC.

SUPN Filings Clear

View A List of Tickers